Literature DB >> 16784819

A neural cell adhesion molecule-derived fibroblast growth factor receptor agonist, the FGL-peptide, promotes early postnatal sensorimotor development and enhances social memory retention.

T Secher1, V Novitskaia, V Berezin, E Bock, B Glenthøj, B Klementiev.   

Abstract

The neural cell adhesion molecule (NCAM) belongs to the immunoglobulin (Ig) superfamily and is composed extracellularly of five Ig-like and two fibronectin type III (F3) modules. It plays a pivotal role in neuronal development and synaptic plasticity. NCAM signals via a direct interaction with the fibroblast growth factor receptor (FGFR). A 15-amino-acid long peptide, the FG loop (FGL) peptide, that is derived from the second F3 module of NCAM has been found to activate FGFR1. We here report that the FGL peptide, when administered intranasally to newborn rats, accelerated early postnatal development of coordination skills. In adult animals s.c. administration of FGL resulted in a prolonged retention of social memory. We found that FGL rapidly penetrated into the blood and cerebrospinal fluid after both intranasal and s.c. administration and remained detectable in the fluids for up to 5 hours.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784819     DOI: 10.1016/j.neuroscience.2006.04.059

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

1.  The Neural Cell Adhesion Molecule-Derived (NCAM)-Peptide FG Loop (FGL) Mobilizes Endogenous Neural Stem Cells and Promotes Endogenous Regenerative Capacity after Stroke.

Authors:  Rebecca Klein; Nicolas Mahlberg; Maurice Ohren; Anne Ladwig; Bernd Neumaier; Rudolf Graf; Mathias Hoehn; Morten Albrechtsen; Stephen Rees; Gereon Rudolf Fink; Maria Adele Rueger; Michael Schroeter
Journal:  J Neuroimmune Pharmacol       Date:  2016-06-28       Impact factor: 4.147

2.  Impact of the neural cell adhesion molecule-derived peptide FGL on seizure progression and cellular alterations in the mouse kindling model.

Authors:  Christina Zellinger; Josephine D Salvamoser; Natalie Seeger; Vera Russmann; Heidrun Potschka
Journal:  ACS Chem Neurosci       Date:  2014-01-23       Impact factor: 4.418

Review 3.  NCAM function in the adult brain: lessons from mimetic peptides and therapeutic potential.

Authors:  Glenn Dallérac; Claire Rampon; Valérie Doyère
Journal:  Neurochem Res       Date:  2013-03-14       Impact factor: 3.996

4.  Tolerability, safety and pharmacokinetics of the FGLL peptide, a novel mimetic of neural cell adhesion molecule, following intranasal administration in healthy volunteers.

Authors:  Ravi Anand; Michael Seiberling; Thierry Kamtchoua; Rolf Pokorny
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

5.  The synthetic NCAM mimetic peptide FGL mobilizes neural stem cells in vitro and in vivo.

Authors:  Rebecca Klein; Stefan Blaschke; Bernd Neumaier; Heike Endepols; Rudolf Graf; Meike Keuters; Joerg Hucklenbroich; Morten Albrechtsen; Stephen Rees; Gereon Rudolf Fink; Michael Schroeter; Maria Adele Rueger
Journal:  Stem Cell Rev Rep       Date:  2014-08       Impact factor: 5.739

6.  An NCAM mimetic, FGL, alters hippocampal cellular morphometry in young adult (4 month-old) rats.

Authors:  Bunmi Ojo; Paul L Gabbott; Payam Rezaie; Nicola Corbett; Nikolay I Medvedev; Thelma R Cowley; Marina A Lynch; Michael G Stewart
Journal:  Neurochem Res       Date:  2012-10-18       Impact factor: 3.996

7.  Antidepressant-like effects of intracerebroventricular FGF2 in rats.

Authors:  Cortney A Turner; Edny L Gula; Larry P Taylor; Stanley J Watson; Huda Akil
Journal:  Brain Res       Date:  2008-06-14       Impact factor: 3.252

Review 8.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

9.  A peptide motif from the second fibronectin module of the neural cell adhesion molecule, NCAM, NLIKQDDGGSPIRHY, is a binding site for the FGF receptor.

Authors:  Jacob Jacobsen; Vladislav Kiselyov; Elisabeth Bock; Vladimir Berezin
Journal:  Neurochem Res       Date:  2008-03-27       Impact factor: 3.996

Review 10.  NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders.

Authors:  Chengyan Chu; Yue Gao; Xiaoyan Lan; Aline Thomas; Shen Li
Journal:  Neurochem Res       Date:  2018-07-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.